Ben Goldacre argues that when a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
Publication bias is research misconduct and fraud:
- Publication bias effects all fields of medicine
- About half of all studies are unpublished
- Positive findings are about twice as likely as negative findings to be published
Ben Goldacre, is a best-selling author, broadcaster, medical doctor and academic who specialises in unpicking dodgy scientific claims from drug companies, newspapers, government reports, PR people and quacks.
On January 16th 2013, Dr Goldachre announced the launch of The AllTrials Campaign.
I am very pleased to announce the launch of a prominent campaign for access to all trial results, which we have launched this week at www.alltrials.net, with myself, Sense About Science, Sir Iain Chalmers from the James Lind Initiative (previously co-founder of Cochrane), Dr Fiona Godlee (Editor in Chief of the BMJ), and Dr Carl Heneghan (Director of the Centre for Evidence Based Medicine at Oxford). The response so far, in a very short period of time, has been phenomenal.
Dr Ben Dr Goldachre
Thanks to Dr Ben Goldacre.